BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ding WY, Gupta D, Wong CF, Lip GYH. Pathophysiology of atrial fibrillation and chronic kidney disease. Cardiovasc Res 2021;117:1046-59. [PMID: 32871005 DOI: 10.1093/cvr/cvaa258] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Ding WY, Gupta D, Wong CF, Lip GYH. Atrial fibrillation in the presence of chronic kidney disease: To ablate or not to ablate. Int J Clin Pract 2021;75:e14723. [PMID: 34670349 DOI: 10.1111/ijcp.14723] [Reference Citation Analysis]
2 Ding WY, Rivera-Caravaca JM, Shantsila A, Marin F, Gupta D, Roldán V, Lip GYH. Outcomes in VKA-treated patients with atrial fibrillation and chronic kidney disease: Clinical trials vs 'real-world'. Int J Clin Pract 2021;75:e13888. [PMID: 33283377 DOI: 10.1111/ijcp.13888] [Reference Citation Analysis]
3 Simard T, Jung RG, Lehenbauer K, Piayda K, Pracoń R, Jackson GG, Flores-Umanzor E, Faroux L, Korsholm K, Chun JKR, Chen S, Maarse M, Montrella K, Chaker Z, Spoon JN, Pastormerlo LE, Meincke F, Sawant AC, Moldovan CM, Qintar M, Aktas MK, Branca L, Radinovic A, Ram P, El-Zein RS, Flautt T, Ding WY, Sayegh B, Benito-González T, Lee OH, Badejoko SO, Paitazoglou C, Karim N, Zaghloul AM, Agrawal H, Kaplan RM, Alli O, Ahmed A, Suradi HS, Knight BP, Alla VM, Panaich SS, Wong T, Bergmann MW, Chothia R, Kim JS, Pérez de Prado A, Bazaz R, Gupta D, Valderrabano M, Sanchez CE, El Chami MF, Mazzone P, Adamo M, Ling F, Wang DD, O'Neill W, Wojakowski W, Pershad A, Berti S, Spoon D, Kawsara A, Jabbour G, Boersma LVA, Schmidt B, Nielsen-Kudsk JE, Rodés-Cabau J, Freixa X, Ellis CR, Fauchier L, Demkow M, Sievert H, Main ML, Hibbert B, Holmes DR Jr, Alkhouli M. Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion. J Am Coll Cardiol 2021;78:297-313. [PMID: 34294267 DOI: 10.1016/j.jacc.2021.04.098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Marini S, Georgakis MK, Anderson CD. Interactions Between Kidney Function and Cerebrovascular Disease: Vessel Pathology That Fires Together Wires Together. Front Neurol 2021;12:785273. [PMID: 34899586 DOI: 10.3389/fneur.2021.785273] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Adão R, Marian AJ. Highlights of American Heart Association Scientific Sessions 2020: a virtual experience. Cardiovasc Res 2021;117:e10-2. [PMID: 33426562 DOI: 10.1093/cvr/cvaa346] [Reference Citation Analysis]
6 Kotalczyk A, Ding WY, Wong CF, Rao A, Gupta D, Lip GYH. Atrial Fibrillation in Patients with Chronic Kidney Disease. Cardiol Clin 2021;39:435-46. [PMID: 34247756 DOI: 10.1016/j.ccl.2021.04.005] [Reference Citation Analysis]
7 Boriani G, Vitolo M, Diemberger I, Proietti M, Valenti AC, Malavasi VL, Lip GYH. Optimizing indices of AF susceptibility and burden to evaluate AF severity, risk and outcomes. Cardiovasc Res 2021:cvab147. [PMID: 33913486 DOI: 10.1093/cvr/cvab147] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
8 Ding WY. Residual Stroke Risk in Atrial Fibrillation. Arrhythm Electrophysiol Rev 2021;10:147-53. [PMID: 34777818 DOI: 10.15420/aer.2021.34] [Reference Citation Analysis]